[ad_1] While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. The central bank has held rates steady since last July as it patiently waits for more signs that …
Read More »Tag Archives: Merck & Co Inc
FDA approves Merck’s drug for rare, deadly lung condition
[ad_1] The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults …
Read More »Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
[ad_1] 3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have …
Read More »Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign …
Read More »Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
[ad_1] Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that …
Read More »Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and valuable market, rivals are still eager to join the race. Bank of America analyst Geoff Meacham has been very bullish about the opportunity, which he calls “unprecedented” given the prevalence …
Read More »New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
[ad_1] Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people of color. Health officials …
Read More »Moderna posts surprise quarterly profit even as Covid vaccines sales plummet
[ad_1] Moderna on Thursday posted a surprise quarterly profit, boosted by deferred revenue and cost cuts, even as the company saw slumping sales from its Covid vaccine, its only marketable product. The results cap a rocky year for the biotech company and other Covid vaccine makers, which all saw revenue plunge …
Read More »Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations
[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday dismissed a lawsuit brought by a major pharmaceutical industry lobbying group …
Read More »Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
[ad_1] Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of Johnson & Johnson, …
Read More »